Spire Inc. (SR) is expected to report Q3 earnings with a forecasted EPS of $-0.46, a 14.81% increase from last year. Zacks reports a 2025 P/E ratio of 20.08, higher than the industry average of 14.60, suggesting strong earnings growth potential compared to competitors.

Scholar Rock Holding Corp. (SRRK) anticipates a $-0.88 EPS for Q3, a 33.33% decrease from last year. Zacks notes a 2025 P/E ratio of -9.26, lower than the industry average of -5.60.

Twist Bioscience Corp. (TWST) expects a $-0.40 EPS for Q3, a 32.20% increase from last year. Zacks reports a 2025 P/E ratio of -15.55, below the industry average of -5.60.

Bit Digital, Inc. (BTBT) forecasts a $0.00 EPS for Q3, a 100.00% increase from last year. Zacks notes a 2025 P/E ratio of -94.67, significantly lower than the industry average of 17.70.

Sigma Lithium Corp. (SGML) projects a $-0.09 EPS for Q3, a 60.87% increase from last year. Zacks reports a 2025 P/E ratio of -19.47, higher than the industry average of -21.10, indicating potential for stronger earnings growth.

Forge Global Holdings, Inc. (FRGE) expects a $-1.00 EPS for Q3, a 33.33% increase from last year. Zacks notes a 2025 P/E ratio of -10.16, lower than the industry average of 9.90.

SBC Medical Group Holdings Inc. (SBC) forecasts a $0.13 EPS for Q3, a 333.33% increase from last year. Zacks reports a 2025 P/E ratio of 6.38, higher than the industry average of 2.60, suggesting strong earnings growth potential.

Gauzy Ltd. (GAUZ) anticipates a $-0.24 EPS for Q3, a 48.94% increase from last year. Zacks notes a 2025 P/E ratio of -3.40, lower than the industry average of 2.60.

MiNK Therapeutics, Inc. (INKT) expects a $-0.86 EPS for Q3, a 72.00% decrease from last year. Zacks reports a 2025 P/E ratio of -3.94, higher than the industry average of -5.60, indicating potential for stronger earnings growth.

Mersana Therapeutics, Inc. (MRSN) projects a $-1.44 EPS for Q3, a 36.00% increase from last year. Zacks notes a 2025 P/E ratio of -8.29, below the industry average of -5.60.

Iterum Therapeutics plc (ITRM) anticipates a $-0.13 EPS for Q3, a 56.67% increase from last year. Zacks reports a 2025 P/E ratio of -1.11, lower than the industry average of 1.10.

LM Funding America, Inc. (LMFA) expects a $-0.49 EPS for Q3, a 68.18% increase from last year. Zacks notes a 2025 P/E ratio of -0.60, significantly lower than the industry average of 9.90.

Read more at Nasdaq: Pre-Market Earnings Report for November 14, 2025 : SR, SRRK, TWST, BTBT, SGML, FRGE, SBC, GAUZ, INKT, MRSN, ITRM, LMFA